Back

Focus Reengineered: Mechanisms and Clinical Data for Pharmacologic Presbyopia Therapies

Pharmacologic therapies are reshaping presbyopia management, introducing new options that act through distinct effects on the pupil and ciliary body. Understanding how these mechanisms translate into clinical efficacy and safety is critical for informed decision-making. In this first episode of a two-part video podcast series, adapted from a live symposium, expert faculty examine key mechanistic distinctions among agents and critically review clinical trial data, including efficacy and safety outcomes across diverse patient populations. Stream the full video or listen on the go with the audio-only version, and download the Presbyopia Pharmacology Fast Facts for a concise clinical reference.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 0.75 creditsAMA PRA Category 1 Credit™Up to 0.75 creditsNursingUp to 0.75 creditsOptometryUp to 0.75 creditsPharmacyUp to 0.75 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Pricing

Free

Reported to ACCME by the provider

  • Podcast / audio
  • includes Article / monograph / reference
  • includes On-demand / recorded video
  • Credit · Up to 0.75 credits
  • Commercial Support
  • Released
    May 4, 2026
  • Last day to claim credit
    May 4, 2027 7 months left